These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881 [TBL] [Abstract][Full Text] [Related]
3. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements. Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005 [TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. Kunze E; Wendt M; Schlott T Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder. Das K; Zhao Y; Sugiono M; Lau W; Tan PH; Cheng C Urol Oncol; 2007; 25(4):317-21. PubMed ID: 17628298 [TBL] [Abstract][Full Text] [Related]
6. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro. Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253 [TBL] [Abstract][Full Text] [Related]
8. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057 [TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder. Liu L; Zhu D; Gao R; Guo H Urol Int; 2008; 81(1):72-6. PubMed ID: 18645275 [TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461 [TBL] [Abstract][Full Text] [Related]
12. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
13. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602 [TBL] [Abstract][Full Text] [Related]
14. Protein expression and gene promoter hypermethylation of CD99 in transitional cell carcinoma of urinary bladder. Xuan Y; Kim S; Lin Z J Cancer Res Clin Oncol; 2011 Jan; 137(1):49-54. PubMed ID: 20217126 [TBL] [Abstract][Full Text] [Related]
15. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Suzuki K; Morita T; Tokue A Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109 [TBL] [Abstract][Full Text] [Related]
17. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression. Yang CC; Chu KC; Yeh WM Urol Oncol; 2004; 22(1):1-6. PubMed ID: 14969795 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
19. EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder. Hinz S; Kempkensteffen C; Weikert S; Schostak M; Schrader M; Miller K; Christoph F Tumour Biol; 2007; 28(3):151-7. PubMed ID: 17541304 [TBL] [Abstract][Full Text] [Related]
20. [Expression of melanoma antigen gene in urinary transitional cell carcinomas]. Geng L; Yu LZ; Du P; Ma M; Na YQ Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]